4.6 Letter

The withdrawal of Activated Protein C from the use in patients with severe sepsis and DIC [Amendment to the BCSH guideline on disseminated intravascular coagulation]

Journal

BRITISH JOURNAL OF HAEMATOLOGY
Volume 157, Issue 4, Pages 493-494

Publisher

WILEY
DOI: 10.1111/j.1365-2141.2011.09019.x

Keywords

Clinical trials; disseminated intravascular coagulation; protein C pathway

Categories

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available